In genetic association studies, detecting disease-genotype association is a primary goal. We study seven robust test statistics for such association when the underlying genetic model is unknown, for data on disease status (case or control) and genotype (three genotypes of a biallelic genetic marker). In such studies, p-values have predominantly been calculated by asymptotic approximations or by simulated permutations. We consider an exact method, conditional enumeration. When the number of simulated permutations tends to infinity, the permutation p-value approaches the conditional enumeration p-value, but calculating the latter is much more efficient than performing simulated permutations. We have studied case-control sample sizes with 500-5000 cases and 500-15,000 controls, and significance levels from 5 × 10 -8 to 0.05, thus our results are applicable to genetic association studies with only a few genetic markers under study, intermediate follow-up studies, and genome-wide association studies. Our main findings are: (i) If all monotone genetic models are of interest, the best performance in the situations under study is achieved for the robust test statistics based on the maximum over a range of Cochran-Armitage trend tests with different scores and for the constrained likelihood ratio test. (ii) For significance levels below 0.05, for the test statistics under study, asymptotic approximations may give a test size up to 20 times the nominal level, and should therefore be used with caution. (iii) Calculating p-values based on exact conditional enumeration is a powerful, valid and computationally feasible approach, and we advocate its use in genetic association studies.
Introduction
In genetic association studies, the aim is to detect a possible association between a phenotype and one or many genetic markers. This can be done for one marker at a time. We will consider biallelic genetic markers, giving three possible genotypes. For each genetic marker the following steps can be performed. (i) First a hypothesis test situation is specified. (ii) This guides the choice of a test statistic. (iii) Then a method to calculate a p-value is chosen. (iv) Finally, the calculated p-value is compared to a chosen significance level to arrive at a conclusion.
A hypothesis test situation may be formulated as "no association between the disease and the genetic marker" versus "association between the disease and the genetic marker." In some genetic studies, in particular for monogenic diseases, the effect of the disease allele on the disease phenotype may be known to follow a specific genetic model, such as dominant, recessive, additive, or multiplicative (e.g., Camp, 1997 ). The genetic model can be used as alternative hypothesis, and a test statistic tailored to detect this type of disease-genotype association can be chosen. For genome-wide association (GWA) studies the underlying genetic model of a disease allele is seldom known (e.g., Devlin and Roeder, 2004) . Therefore, it is desirable to base the statistical inference on a test statistic that gives high power over a wide range of genetic models. These types of test statistics are commonly referred to as robust test statistics (Freidlin et al., 2002) . We will restrict our attention to performance under what we will call monotone genetic models, under which the genetic effect of the heterozygous genotype lies between the two homozygous genotypes. We will investigate which of the available popular robust test statistics are most suitable in terms of power and keeping size at nominal level when the underlying genetic model is unknown, but monotone.
Two approaches that have been used to calculate p-values for disease-genotype association are asymptotic methods and simulated permutations (Sladek et al., 2007) . We will argue that exact conditional enumeration, which is the same as exact permutation testing, yields the same p-values as permutation when the number of permutations tends to infinity, and that, for the sample sizes and low significance levels considered here, exact conditional enumeration is less computationally intensive than simulated permutations. We will therefore consider asymptotic methods and exact conditional enumeration in the size and power study. We will also discuss the number of simulated permutations needed to have a reasonable probability of detecting a result that would be significant if exact conditional enumeration were used. Many other ways of calculating p-values exist, see Langaas and Bakke (2013) for a presentation of unconditional enumeration methods for discrete distributions suitable for small to moderate sample sizes.
Exact conditional enumeration is a general method by which the p-value of an outcome is calculated based on a test statistic and the conditional probabilities of all possible outcomes of the conditional experiment in question. The most popular use of exact conditional enumeration is Fisher's exact test. There is a large body of literature on hypothesis testing in 2 × 2 contingency tables, where conditional tests are found to be less powerful than unconditional alternatives (Mehrotra et al., 2003; Lydersen et al., 2009 ). Our focus is on disease-genotype association for a biallelic marker in a case-control setting, which means that the data can be presented in a 2 × 3 contingency table where row margins are fixed by experimental design. The conditioning is done on the column margins, and the conditional probability of an outcome is a trivariate hypergeometric probability. Some researchers have found that because of the less discrete nature of higher order contingency tables, the power disadvantage of the conditional test tends to be less pronounced than for the 2 × 2 contingency table (Mehta and Hilton, 1993) .
For larger contingency tables, exact conditional enumeration has been believed to require substantial computer resources (enumeration and summation of probabilities) and thus not to be feasible for testing for disease-genotype association. We will show that even for large sample sizes, 5000 cases and at least 5000 controls in a 2 × 3 contingency table, exact conditional enumeration can be performed in a fraction of a second on a standard computer. Turning to the asymptotic methods, it is known that asymptotic methods will not preserve test size in situations where the asymptotic approximation is poor. We will investigate whether asymptotic or exact conditional enumeration methods are most suitable to use in terms of power, test size and computational resources when testing disease-genotype association using a robust test statistic, in addition to the above-mentioned comparison between exact conditional enumeration and simulated permutations.
In genetic association studies, multiple testing correction is commonly performed by controlling the familywise error rate by the Bonferroni method. When a single genetic marker is studied, a significance level of α = 0.05 is commonly used. For larger candidate studies, or follow-up studies, with 10-1000 genetic markers under study, significance levels of the order 5 × 10 -3 -5 × 10 -5 may be used. For GWA studies with ten thousand to one million genetics markers, significance levels 5 × 10 -6 -5 × 10 -8 have been used (The Wellcome Trust Case Control Consortium, 2007) . We will study significance levels in the range 5 × 10 -2 -5 × 10 -8 , and sample sizes in the range 500-5000 cases and 500-15,000 controls.
The presentation is organized as follows. In Section 2 we present notation, data structure, test statistics, methods for calculating p-values and estimation of power. We then present the results of a large simulation study to compare the power of different robust test statistics combined with either the asymptotic method or the exact conditional enumeration method in Section 3. We discuss in Section 4 and conclude in Section 5.
Methods

Notation and data
We will to some extent adopt the notation of Joo et al. (2009) and Langaas and Bakke (2013) . We assume that genotypes and a dichotomous phenotype (diseased or not) are collected in a case-control study, and that the genotype data are from biallelic genetic markers with alleles a and A. For each genetic marker, we assume that A is the high risk allele, and index the three genotypes aa, aA, and AA, by 0, 1, 2, respectively. Further, for each genetic marker let g 0 , g 1 and g 2 be the genotype frequencies for the three genotypes in the population under study, p 0 , p 1 , and p 2 the genotype frequencies of the case population (disease phenotype) and q 0 , q 1 , and q 2 the genotype frequencies of the control population.
For each genetic marker we may present the collected data in a 2 × 3 contingency table (Table 1 ). The number of cases and controls with genotype i is denoted by x i and y i , respectively, and the total number of cases and controls with genotype i by m i = x i +y i , i = 0, 1, 2. Let n 1 = x 0 +x 1 +x 2 denote the total number of cases, n 2 = y 0 +y 1 +y 2 the total number of controls, and let N = n 1 +n 2 = m 0 +m 1 +m 2 .
The vectors (x 0 , x 1 , x 2 ) and (y 0 , y 1 , y 2 ) are considered to be independent and trinomially distributed with parameters (n 1 ; p 0 , p 1 , p 2 ) and (n 2 ; q 0 , q 1 , q 2 ), respectively. The probability of a disease-genotype table with entries z = (x 0 , x 1 , x 2 , y 0 , y 1 , y 2 ) for a given set of parameters θ = ( p 0 , p 1 , p 2 , q 0 , q 1 , q 2 ) is
Statistical hypotheses and genetic models
Let k be the disease prevalence, and let f i be the penetrance, i.e., the conditional probability of disease, given genotype i. Then p i k = f i g i and q i (1-k) = (1-f i )g i for i = 0, 1, 2. The null hypothesis that we will investigate is that the penetrances are equal for the three possible genotypes,
which can be shown to be equivalent to p i = q i for i = 0, 1, 2. Further, denote by λ 1 = f 1 /f 0 and λ 2 = f 2 /f 0 the genotype relative risks. Then k = f 0 (g 0 +λ 1 g 1 +λ 2 g 2 ). We define a genetic model to be monotone if
or alternatively, 1 ≤ λ 1 ≤ λ 2 , which can be shown to be equivalent to p 0 /q 0 ≤ p 1 /q 1 ≤ p 2 /q 2 . As alternative hypotheses we consider monotone genetic models where at least one of the inequalities are strict. Those models can be parameterized by 
where λ 2 > 1 and 0 ≤ δ ≤ 1. The value δ = 0 yields the recessive genetic model, δ = 1/2 the additive genetic model, and δ = 1 the dominant genetic model. We will refer to the genetic model with δ = 1/4 as semi-recessive and δ = 3/4 as semi-dominant.
Test statistics and asymptotic distributions
We now consider test statistics for testing the null hypothesis (2) against the alternative of a general monotone genetic model (4) or some specified monotone genetic model. The potential high risk allele is often unknown. Therefore all tests will be two-sided, in the sense that the conclusion of the test will be the same if the data for each homozygote are swapped.
Cochran-Armitage trend test (CATT 1/2 )
The Cochran-Armitage test for trend (Cochran, 1954; Armitage, 1955) 
is used in disease-genotype association testing with scores (s 0 , s 1 , s 2 ) = (0, s, 1) (Sasieni, 1997; Slager and Schaid, 2001) , and we use the notation CATT s for CATT with those scores. It can be used to test the null hypothesis (2) against a specific genetic model. The value of s is chosen as s = 0, 1/2, 1 for the recessive, additive and dominant model of (4), respectively (Zheng et al., 2003) . Asymptotically, CATT s follows a standard normal distribution under the null hypothesis. A large value of |CATT s | indicates rejection of the null hypothesis. CATT 1/2 is also used as a test statistic when the genetic model under the alternative is unknown, and we include it in our study.
Pearson χ 2 test (Pearson)
The well-known Pearson test statistic,
is not tailored to be powerful for monotone genetic models (3) in particular but rather to test against the more general alternative that f 0 , f 1 and f 2 are not all equal. Under the null hypothesis, for our 2 × 3 situation, it asymptotically follows a χ 2 distribution with two degrees of freedom. A large value indicates rejection of the null hypothesis.
Minimum p-value test (MIN2)
The statistic MIN2 is defined as the minimum of the asymptotic p-values of CATT 1/2 and of the Pearson χ 2 statistic. It is not a valid p-value itself, but its asymptotic distribution under the null hypothesis is given by
where q is the 1-t quantile of the χ 2 distribution with one degree of freedom . A small value indicates rejection of the null hypothesis.
Maximum Test (MAX3)
The statistic MAX3 = max(|CATT 0 |, |CATT 1/2 |, |CATT 1 |) was proposed as an alternative to CATT when the genetic model is unknown but monotone, with emphasis on the recessive, additive and dominant model (Freidlin et al., 2002) . Its asymptotic distribution is given by
are coefficients making CATT 1/2 →ω 0 CATT 0 +ω 1 CATT 1 asymptotically,
is the asymptotic correlation coefficient of CATT 0 and CATT 1 under the null hypothesis (2), and φ and Φ are the standard normal pdf and cdf, respectively (Zang et al., 2010) . When the asymptotic p-value is computed by (5), g 0 , g 1 and g 2 must be replaced by their consistent estimators m 0 /N, m 1 /N and m 2 /N, respectively.
Constrained maximum test (CMAX)
The constrained maximum test statistic,
where s = (x 1 /m 1 -x 0 /m 0 )/(x 2 /m 2 -x 0 /m 0 ) , follows a distribution given by (6)), φ and Φ are the standard normal pdf and cdf, respectively, and F the cdf of the χ 2 distribution with two degrees of freedom. Again, g 0 , g 1 and g 2 enter into ρ and must be replaced by their consistent estimators m 0 /N, m 1 /N and m 2 /N, respectively, to compute an asymptotic p-value.
Constrained likelihood ratio test (CLRT)
CLRT is the likelihood ratio test statistic, but the maximum under the alternative hypothesis is taken under the constraint of the genetic model being monotone (see Section 2.2 and start of Section 2.3). Let 
where s is defined in Section 2.3.5. This is the same statistic as obtained by Wang and Sheffield (2005) , who showed that CLRT has the same asymptotic distribution under the null hypothesis as described for CMAX (Section 2.3.5).
Maximin efficiency robust test (MERT)
A maximin efficiency robust test (Gastwirth, 1985) can be constructed from CATT 0 and CATT 1 , giving 0 1 (Zheng et al., 2006) . It has an asymptotic standard normal distribution under the null hypothesis. A large value of |MERT| indicates rejection of the null hypothesis.
Using conditional enumeration or simulated permutations to calculate p-values
Exact conditional enumeration
When an outcome z = (x 0 , x 1 , x 2 , y 0 , y 1 , y 2 ) is presented as a contingency table (Table 1) the column margins are m 0 = x 0 +y 0 , m 1 = x 1 +y 1 and m 2 = x 2 +y 2 . The unconditional probability under the null hypothesis of the outcome is given by (1) with all p i and q i replaced by g i . When we condition on the column margins M(z) = (m 0 , m 1 , m 2 ), the probability under the null hypothesis of an outcome z is a trivariate hypergeometric probability
showing that the column margins are sufficient statistics for the genotype frequencies g i . Any test statistic T (e.g., one of the statistics of Section 2.3) defines an exact conditional p-value of an outcome z conditioned on its column margins M(z). It can be calculated by the sum
(it is assumed that large values of T indicate rejection of the null hypothesis). The number of summands in (8) is much smaller than it would have been without conditioning, making summation also feasible for rela-tively large studies. Bakke and Langaas (2012) found a formula for the maximum number of summands in (8) when n 1 , n 2 are fixed and m 0 , m 1 , m 2 vary. This maximum is always less than or equal to 1 2 . 2 Table 2 . Moldovan and Langaas (2013) show in a worked-through example how to calculate the exact conditional enumeration p-value p(z) using the MAX3 test statistic. For some test statistics T the network algorithm of Mehta and Patel (1983) might be of use to calculate p(z). Tian and Xu (2013) gave an efficient algorithm to calculate p(z) when T = MAX3.
Simulated permutations
We have seen that the outcome of an experiment can be presented as a contingency table z = (x 0 , x 1 , x 2 , y 0 , y 1 , y 2 ). The outcome may alternatively be given more detailed on the individual level as two vectors of length N, one giving disease status and one giving genotype status. Thus, entry l in the disease vector gives the disease status of individual l and entry l in the genotype vector gives the coded genotype of individual l. In permutation testing, one of the vectors are fixed, and all permutations of the other vector, say, the genotype vector, are considered. Under the null hypothesis, the outcome defined by each permutation should be equally probable, and the exact permutation p-value of z can be calculated as the proportion of permutations giving a test statistic greater than or equal to T(z) among all permutations.
The number of permutations,
will typically be huge, e.g., 299 1000 2.7 10 500
usually a large number b of permutations are simulated and the proportion of the b+1 outcomes (the original outcome and the b permutation outcomes) having a value of the test statistic greater than or equal to T(z) serves as a p-value. It tends to the exact permutation p-value described above as b tends to infinity.
Relationship between exact conditional enumeration and simulated permutations
In our case, however, with only three possible entries, 0, 1 or 2, in the permuted genotype vector, the number of different outcomes (presented as contingency tables) is drastically reduced. In fact, drawing a random permutation corresponds exactly to performing a trivariate hypergeometric experiment, drawing genotypes of the n 1 cases from the m 0 , m 1 , m 2 of each genotype, which gives the probability given in (7) for the table defined by the permutation. The tables defined by permutations are exactly those having the same row and column margins as z, so the exact permutation p-value is equal to the exact conditional enumeration p-value.
For the tests considered in the present work, exact conditional enumeration is preferable to simulated permutations when the significance level is low, even for large sample sizes n 1 and n 2 . For GWA studies, a significance level of α = 5 × 10 -8 is routinely used. For the possibility even to exist that the p-value p(z) is equal to or less than α, the number b of simulated permutations must be at least 2 × 10 7 -1. Then the p-value is equal to α if and only if all test statistics of the permutations are less than T(z).
Even if rejection of the null hypothesis is possible, it may still not be very probable. Since p(z) is the probability that a random permutation will have a test statistic greater than or equal to T(z), the number X of the b random permutations with this property has the binomial distribution with parameters b and p(z). Table 2 Maximum number N * of tables with given column margins for sample size n 1 cases and n 2 controls. This will be the maximum number of summands when calculating the exact conditional enumeration p-value in Equation (8). The notation ≥ i means that N * is the same for all n 2 ≥ i. As an example, consider an outcome z having an exact conditional p-value of p(z) = 4 × 10 -8 , which would lead to rejection at the 5 × 10 -8 level. With b = 2 × 10 7 -1 permutations, the probability that simulated permutations will lead to rejection is (1-p(z)) b = 0.449. Paradoxically, as b increases to 4 × 10 7 -2, the probability of rejection decreases monotonically ( Figure 1) . The reason is that the requirement for rejection based on z is still that none of the permutations have a greater test statistic than T(z), so the probability of rejection drops all the way down to (1-p(z)) b = 0.202 for b = 4 × 10 7 -2.
In general, for the random permutation test to lead to rejection at the 5 × 10 -8 level, we must have (X+1)/ (b+1) ≤ 5 × 10 -8 , where X has the binomial distribution described above. For b = 4 × 10 7 -1, X = 1 leads to rejection in addition to X = 0, and the probability of rejection by simulated permutations jumps up to 0.525. A probability of rejection of 0.8 is first reached when b = 3.8 × 10 8 -1. The probability exceeds 0.8 for all b ≥ b 0 only when b 0 is as large as 5.2 × 10 8 -1. In contrast, using (8) directly is much more efficient, as can be seen from Table 2 . A comparison of simulated permutations and exact conditional enumeration is given in Table 3 .
For an outcome having exact conditional p-value 4.9 × 10 -8 , which also leads to rejection, the corresponding numbers are b = 3.562 × 10 10 -1 to reach probability 0.8 of rejection and b = 3.754 × 10 10 -1 to have probability > 0.8 for all higher b.
If simulated permutations are to be used, it follows from the discussion above that the number of permutations should be chosen as a multiple of the reciprocal of the significance level (minus 1), as other choices will lead to higher permutation p-values and hence less test power. 10,000 20,000 30,000 40,000 that must be concidered in exact conditional enumeration. Dotted lines: To obtain a probability of 0.8 of rejection, 3.8 × 10 8 simulated permutations must be performed. This is the same number of tables that one would, at most, have to go through to calculate an exact conditional p-value for an experiment having 27,566 cases. The corresponding number to obtain a probability of 0.9 are 7.8 × 10 8 permutations, which is the worst-case number of tables to consider for a study with 39,495 cases.
Number of cases
Simulated permutations are useful if the min p or max T method of Westfall and Young (1993) is to be used for testing multiple hypotheses, as the distribution of the minimum p-values or the distribution of the maximum of the test statistic under permutations is required. Still, the raw p-values used in min p can be exact conditional. Also, in other settings than considered by us, for example logistic regression with other covariates in addition to genotype, the reduction in the number of possible values of the test statistic will not take place, and exact conditional testing is at present not an alternative to simulated permutations.
Validity of p-values
For a chosen significance level α and an outcome z, the null hypothesis is rejected if the p-value p(z) ≤ α. For a test to keep its size at the nominal level, the probability of rejection under the null hypothesis should be less than or equal to α, i.e., Pr(p(Z) ≤ α) ≤ α for all α and all parameters under the null hypothesis. Such a p-value is called valid (Casella and Berger, 2001, p. 397) .
When calculating a p-value based on the asymptotic distribution of a test statistic, there is no reason to believe that this will be a valid p-value for the sample size under study. The conditional enumeration p-value defined in Section 2.4, is on the other hand always valid, not only considered as a p-value when the experiment is conditioned on M(Z), but also considered as a p-value for the original experiment (here case-control) (Casella and Berger, 2001, p. 399) . The simulated permutations p-value is not only an approximation of the conditional enumeration p-value, but is also a valid p-value in itself (see e.g., Phipson and Smyth, 2010 ).
Power
Desirable properties of a p-value are validity and high power (the probability to reject H 0 ). If the sample space is discrete, the power at a parameter vector θ of a test defined by p(Z) for a given α is
where the probabilities depend on the parameter vector θ, and the summation is over all outcomes z having a p-value not greater than α. The probability Pr θ (Z = z) is given by (1). The test size is sup θ∈Θ 0 γ(θ), where the supremum is taken over all parameter vectors under the null hypothesis. Table 3 The minimum number, b, of simulated permutations needed to give probability 0.8 or 0.9 of rejecting the null hypothesis of no association based on an experiment having exact conditional p-value 20% below the significance level. Also n 1 such that 1 2 2
is the upper bound for the number of different contingency tables with fixed margins (which must be gone through in exact conditional enumeration) for a case-control experiment with n 1 cases. For example, an experiment giving an exact conditional p-value of 4 × 10 -8 would need 3.8 × 10 8 simulated permutations for the simulated permutation p-value to be below 5 × 10 -8 with probability 0.8. In the worst case, the same number of tables would be needed to go through to find the exact conditional p-value in a case-control experiment with 27,566 cases. In our set-up, explained in detail in Section 3, the number of summands in (9) is maximally 1 2 1 2 2 2 , n n n n
Level
which becomes too large for practical use for the sample sizes we consider. We instead estimate test size and power using simulation. We base our calculations on b independent random draws from the probability distribution (1) for the data. Let p(z i ) be the calculated p-value (asymptotic or exact conditional, for any of the seven test statistics) for drawing i. Then the estimated power is
where I is the indicator function having value 1 if p(z i ) ≤ α and 0 otherwise. That is, the power (or test size) is estimated as the fraction of p-values below α for the b independent random draws from the parameter vector θ. Although test size and power were estimated, the exact conditional p-values of each simulated table were calculated exactly by (8) and not by simulations.
A study on test size and power
We investigated size and power using p-values from the asymptotic approximations and the exact conditional enumeration for the seven statistics of Section 2.3. Simulated permutations were not considered, as the p-values of that method will converge to those of exact conditional enumeration as the number of permutations tends to infinity.
Set-up
In most genetic association studies the number n 1 of cases does not exceed the number n 2 of controls. We also made this assumption. We considered both balanced and unbalanced designs. For n 1 equal to 500 or 1000, we considered n 2 to be 1, 2, 3, 4, 5 times n 1 . For n 1 = 5000, we considered n 2 to be 1, 2, 3 times n 1 . Thus, we considered 13 sample sizes (n 1 , n 2 ) in total.
Our data generation procedure was inspired by Joo et al. (2009) . We studied a disease prevalence of 10%, since genetic association studies in general are designed to target common diseases. Most GWA studies are based on single nucleotide polymorphisms (SNPs) with minor allele frequency (MAF) at least 5%. We chose a MAF of 10%, and we only considered populations under Hardy-Weinberg equilibrium, which gives genotype frequencies g 0 = (1-MAF) 2 = 0.81, g 1 = 2MAF(1-MAF) = 0.18, g 2 = MAF 2 = 0.01. We assumed that the minor allele is also the disease allele. For each situation under study (see below) we calculated θ = (p 0 , p 1 , p 2 , q 0 , q 1 , q 2 ) based on the formulas in Section 2.2, and drew data from the probability distribution (1).
Under the null hypothesis of equal penetrances for the genotypes, we drew 4 × 10 9 samples from the study population. For this number of drawn samples, assuming a valid test at significance level 5 × 10 -8 , an approximate 95% confidence interval for the test size has half-length 8 8 9 9
1.96 5 10 (1 5 10 ) /(4 10 ) 7 10 . − − − × × × − × × = × We also studied populations under alternative hypotheses, as presented in Section 2.2. Parameters chosen for the alternative hypotheses were the genotype relative risk λ 2 = 1.1, 1.2, 1.5, 2 and the genetic model parameter δ = 0, 1/4, 1/2, 3/4, 1. The genotype relative risk λ 1 was calculated from δ and λ 2 using (4).
For all the possible combinations of λ 2 and δ (as given above), and for each of the 13 sample sizes (4 × 5 × 13 = 260 situations), we drew one million random samples from the population described by these parameter values. With this number of samples, for a true power of 0.8, we achieved an approximate 95% confidence interval for the power with half-length 6 4 1.96 0.8 (1 0.8) /(1 10 ) =8 10 . − × × − × × For each sample drawn we calculated the asymptotic and the exact conditional enumeration p-values for the seven test statistics (CATT 1/2 , Pearson, MIN2, MAX3, CMAX, CLRT and MERT) under study, and estimated the test size or power as the relative number of p-values falling below the significance levels investigated (10). For evaluation of test size and power we studied results for significance levels α in the range 5×10 -i , i = 2, 3,..., 8.
We did not include simulated permutation p-values in the study, since those are asymptotically equal to the exact conditional p-values.
Computational details
The numerical calculations were performed in the C++ language of the GNU Compiler Collection 4.4.3. For generating multinomial vectors, making statistical distribution calculations and numerical integration, the GNU Scientific Library 1.13 was used. To reduce computation time, the parallel language extension OpenMP was used to distribute the generation of tables and subsequent statistical calculations among several threads operating on different processors.
For the asymptotic method, power calculations in the case of CATT 1/2 , Pearson, MIN2 and MERT were done by comparing test statistics for simulated data with critical values, which is faster than calculating p-values explicitly. In the case of MAX3, CMAX and CLRT, p-values depend on estimated parameters, and had to be calculated for each drawn sample.
For the exact conditional enumeration method, to avoid numerical overflow, the hypergeometric probabilities (7) were calculated by adding logarithms of factorials and then taking the antilogarithm. To gain speed, the ln l! were computed once and tabulated for l = 0, 1,..., N.
The exact conditional p-value of a drawn sample (x 0 , x 1 , x 2 , y 0 , y 1 , y 2 ) was found by (8). The summation was done over tables having the same margins as the drawn sample. Those tables are determined by their two upper left entries u and v (corresponding to x 0 and x 1 ) and the conditions max(0, m 0 -n 2 ) ≤ u ≤ min(m 0 , n 1 ), max(0, m 0 +m 1 -n 2 -u) ≤ v ≤ min(m 1 , n 1 -u).
If, for a drawn sample (x 0 , x 1 , x 2 , y 0 , y 1 , y 2 ), during the summation of the exact conditional enumeration p-value by (8), the sum for all seven statistics T had exceeded the highest significance level considered, 0.05, the evaluation was aborted, since the table would then not contribute in the summation of power (10).
Also, to speed up the time for such a potential early abortion of the summation by (8), the summation was started at tables potentially having a high conditional probability (7), namely those having u = x 0 as the upper left entry. Then tables having x 0 +1 as the upper left entry were considered and so on upwards, and thereafter the process was repeated going from x 0 -1 downwards.
On a 4 × 6-core Xeon 2.67 GHz computer (Intel CPU) running Linux (Ubuntu 10.4), using one tread, the computation of exact conditional enumeration p-values for 1000 tables with sample size n 1 = 5000 and n 2 = 15,000 drawn from the null hypothesis took under 14 s. The corresponding computation for 1000 such tables drawn under an alternative hypothesis having power near 100% for all test statistics, took under two minutes. Calculation of the exact conditional enumeration p-value is faster when tables are drawn from the true null hypothesis than when tables are drawn from the alternative hypothesis. This is because p-values calculated for tables generated under the null hypothesis are in general larger than p-values for tables generated under the alternative hypothesis, and we abort calculations once the p-value reaches 0.05.
For smaller sample sizes, computations are much faster. For n 1 = n 2 = 1000 the timings for 1000 tables are 0.3 s for the null hypothesis and 2 s for the alternative.
Effect of significance level and sample size
In Section 2.5 we pointed out that there is no guarantee that asymptotic methods keep the test size at the nominal level, while the exact conditional methods are always valid by construction. However, for α = 0.05 we found that the asymptotic methods for nearly all test statistics (except CLRT) kept the nominal level at the chosen genotype frequencies (g 0 , g 1 , g 2 ) = (0.81, 0.18, 0.01) for all sample sizes investigated. With the exception of CLRT, we get an increasing degree of mismatch between size and nominal level for the asymptotic methods when α decreases to 5 × 10 -8 . Worst are MAX3 and CMAX for small and unbalanced designs, with a type I error probability of up to 20 times the nominal level. For low levels, MAX3, Pearson, MIN2, MERT and CMAX keeps under 1.2 times the level only for balanced designs and for designs having the number of controls twice the number of cases. CATT 1/2 fares a little better, but at worst has a type I error probability twice the nominal level, and CLRT is always within 1.5 times the level. To emphasize the need to use exact conditional methods instead of asymptotic methods for low significance levels and unbalanced sample sizes, Table 4 gives type I error probabilities for significance level 5 × 10 -7 for the asymptotic method.
As expected, power increases with increasing sample sizes and with increasing significance levels. Keeping the total sample size fixed, the highest power is observed for balanced sample sizes and decreases with increasing degree of unbalance. This can be observed (Table 5) for the sample size combinations (n 1 , n 2 ) = (500, 1500) and (1000, 1000), both giving total sample size 2000, and this is also the case for (500, 2500) and (1000, 2000) , with total sample size 3000. Table 4 Type I error probability for test statistics, balanced and unbalanced sample sizes, for the asymptotic method for significance level α = 5 × 10 -7 . Genotype frequencies are (g 0 , g 1 , g 2 ) = (0.81, 0.18, 0.01). The probabilities shown are multiplied by 10 7 , so that 5.00 would indicate an exact test. 4 × 10 9 simulations were run, giving 95% confidence interval half-lengths of 2.2 × 10 -8 for true test sizes 5 × 10 -7 . n 1 n 2 CATT 1/2 Pearson MIN2 MAX3 CMAX CLRT MERT Table 5 Power (in per cent): Effect of test statistic, method (A asymptotic, C exact conditional) and sample size (n 1 cases, n 2 controls). The genetic model is semi-dominant (δ = 3/4), genetic relative risk λ 2 = 1.5 and significance level α = 5 × 10 -5 .
Effect of genetic model
Since the asymptotic methods do in general not provide valid p-values, we base our discussion on comparing power based on the exact conditional enumeration p-values. But, the power of the invalid asymptotic methods will in general not be substantially larger than the power of the valid exact conditional methods, which is seen in Tables 5-7 . Table 6 Power (in per cent): Effect of test statistic, method (A asymptotic, C exact conditional), genetic model (δ = 0 recessive, δ = 1 dominant) and genetic relative risk (λ 2 ). Sample size is (n 1 , n 2 ) = (5000, 15,000) and significance level α = 5 × 10 -6 . Table 7 Power (in per cent): Effect of test statistic, method (asymptotic, A, and exact conditional, C) and sample size (n 1 cases, n 2 controls) for significance level α = 5 × 10 -8 . Values of genetic model δ and genotype relative risk λ 2 are chosen to give power closest to 80%. For each sample size the most powerful combination of method and test statistic is given in italic, while the most powerful exact conditional enumeration method and test statistic is given in boldface. We have chosen to only study monotone genetic models, and we find that the effect of genetic model seems to be similar for all sample sizes and significance levels. Results for (n 1 , n 2 ) = (5000, 15,000) and α = 5 × 10 -6 are shown in Table 6 . For all combinations of test statistic and method, power increases with increasing dominance (δ) and genetic relative risk (λ 2 ). For the recessive model (δ = 0), CMAX and MAX3 perform the best (with very similar powers). The CATT 1/2 performs poorly for the recessive model, as compared to all the other test statistics studied. The most extreme situation observed was for sample size (5000, 15,000) for λ 2 = 2 and α = 5 × 10 -6 , where CATT 1/2 gives a power of 4.6% while the MAX3 gives a power of 88.5% (Table 6 , fourth row from the top).
For the semi-recessive model (δ = 1/4) MERT gives the best performance (Table 6, rows 5-8) . For the additive model (δ = 1/2), CATT 1/2 performs the best. This is also true for the semi-dominant (δ = 3/4) and the dominant (δ = 1) models. The MERT test statistic has for these three genetic models lower power than the other test statistics.
General findings
From the results of our power study, we may divide the test statistics into four groups based on their overall performance. (i) The CATT 1/2 has very good performance for all models other than the recessive, (ii) MERT performs well for the semi-recessive model, but else has a less good performance, (iii) the three test statistics MAX3, CMAX and CLRT have very similar performance and give good results for all genetic models, and lastly, (iv) Pearson and MIN2 also have very similar performance, in general slightly less powerful than the previous group, but also work well for non-monotone genetic models .
In Table 7 we present powers for α = 5 × 10 -8 for all the sample sizes under study. For each sample size we have chosen the genetic model and effect size (λ 2 ) that give power (over all test statistics) closest to 80%. These results are influenced by a selection bias due to the fact that for small sample sizes only the dominant models with large effects sizes will achieve power near 80%, and for large sample sizes power near 80% will be achieved for additive to recessive models. Taking this into mind, we see that the general results presented above are reflected in this table.
Discussion
Parameter choices in the simulation study
In the simulation study (Section 3), all data have been drawn assuming that the disease prevalence is k = 0.1, the minor allele (disease allele) frequency is MAF = 0.1, and that the total population is in Hardy-Weinberg equilibrium (HWE). Further, we have only studied monotone genetic models with low to moderate effect size λ 2 and sample sizes in the order 500-5000 cases and 500-15,000 controls. The conclusions to be drawn from the simulation study are thus only valid for these situations. However, some observations on the effect of changes to the set-up may be drawn.
The data are simulated in a case-control design. Keeping all other parameters fixed (λ, δ, MAF), it is easy to see that the effect of doubling the disease prevalence is to double the probability of disease for each genotype. This will leave the genotype probabilities for the cases unchanged, and will only change the genotype probabilities for the controls slightly. We believe that the effect of changing the disease prevalence in our study will be minor.
There is a straightforward effect of changing the MAF. The simulation study used MAF = 0.1, and lowering the MAF will, most importantly, lead to a lower disease type homozygote frequency, g 2 = MAF 2 . This will in turn lead to a greater imbalance in the expected cell counts for the six contingency table cells, influencing the validity of the asymptotic approximations in a negative manner.
Since we are working with test statistics that are based on genotype data, there is no need to assume HWE. We may generate data deviating from HWE by introducing an inbreeding coefficient when calculating genotype frequencies. In a data model with positive inbreeding coefficient, the two homozygote genotype frequencies will increase and the heterozygote frequency will decrease. We believe this will influence the disease homozygote group the most, and that this in turn will lead to a better balance in the expected cell counts for the six contingency table cells, thus, influencing the asymptotic approximations in a positive manner.
Ranking of genetic markers
For candidate studies and intermediate follow-up studies, producing a p-value for each genetic marker is in general of interest, while for GWA studies the main objective may be to provide a ranking of the genetic markers (with respect to increasing strength of the disease-genotype association).
Assume that in a case-control study with n 1 cases and n 2 controls we have studied m genetic markers. These markers may in general come from a population with different genotype frequencies for each marker. The collected data would typically have different column margins.
For the test statistics CATT 1/2 , Pearson, MIN2 and MERT, the asymptotic null distribution of the test statistics does not depend upon any unknown parameters, and also not on n 1 and n 2 . This means that the rank of the m genetic markers according to each of these test statistics will be the same as the rank according to the corresponding asymptotic p-value. For the test statistics MAX3, CMAX and CLRT the asymptotic null distribution is dependent on the estimated value of the genotype frequencies g 0 , g 1 , g 2 . The ranking of the genetic markers by test statistic may differ from the ranking by the asymptotic p-values, but we believe that the difference in ranking is minor. For the ranking of the test statistics as compared to the ranking of the exact conditional enumeration p-value, the ranking of the exact conditional enumeration p-value will only be the same as the ranking of the test statistic for genetic markers with identical column margins. In a GWA study the ranking of the genetic markers based on a test statistic will be different from the ranking based on exact conditional enumeration p-values. To which extent the rankings differ may be a topic of further study.
Validity and asymptotic methods
When a p-value is calculated and used to guide the acceptance or rejection of one or many null hypotheses we would like to advocate using methods that produce valid p-values. Otherwise, violations of the single or multiple type I error will lead to loss of type I error control, and to optimistic power calculations.
The lack of validity of the p-values from asymptotic methods for low significance levels is in general not surprising (see e.g., Morris and Elston, 2011) .
The validity of the asymptotic Pearson p-value has been studied extensively. Cochran (1954) formulated a rule of thumb for using the asymptotic validity of the χ 2 approximation for contingency tables larger than 2 × 2: "If relatively few expectations are < 5 (say in 1 cell out of 5 or more, or 2 cells out of 10 or more), a minimum expectation of 1 is allowable in computing χ 2 ." In our simulation study, the expected cell counts under the null hypothesis were g i n 1 and g i n 2 for genotypes i = 0, 1, 2 for cases and controls, respectively, which gave the smallest expected cell count of g 2 n 1 = 0.01·500 = 5 over all our simulations. Nevertheless, we found that the asymptotic p-value for the Pearson test did not keep test size at the nominal level, especially for unbalanced sample sizes and low significance levels, even if all cells had expected count at least 5. Wise (1963) found that errors in the χ 2 approximation in a multinomial situation are particularly small when the expected cell counts are equal or nearly so, and that these expected cell counts need not be large. Our results point towards a greater effect of equality in expected cells counts than of the numerical values of the expected cell counts. This can be seen by comparing the test sizes in Table 4 . For n 1 = 500, observe that for the Pearson test statistic (and also for the MIN2, MAX3, CMAX and MERT), the violations in test size increase as n 2 increases from 500 to 2500. When n 2 increases, the expected cell counts for the controls will increase, but the difference between the expected cell counts between the cases and controls will also increase. The same pattern is seen for n 1 = 1000 as n 2 increases. We believe that the observations on equality of expected cell counts for the Pearson test statistic will also apply to the other test statistics.
Covariates and logistic regression
All the methods considered in this presentation only use information on the disease phenotype and the genotype in order to calculate test statistics and p-values. However, data on covariates may also have been collected. It is believed that complex diseases may be the result of an interplay between genetic markers, clinical covariates and environmental covariates. In addition, genetic confounders, e.g., population stratification, may be present, and can be taken into account by constructing genetic covariates based on, e.g., principal component analysis of GWA data (Price et al., 2006) , or by scaling the test statistic (genomic control, Devlin and Roeder, 2004) before calculating a p-value based on an asymptotic approximation.
The asymptotic CATT s test can be performed by first fitting a logistic regression to the disease status as response and genotype as a covariate having levels 0, s, 1, and then performing an asymptotic score test (Tarone and Gart, 1980) . The logistic regression is easily extended to include further covariates, and interactions between covariates and genotype. Pirinen et al. (2012) state that the asymptotic properties of the logistic regression model can be trusted for large GWA studied of common variants (MAF larger than 0.05). Comparing this to our finding for CATT s we reach the same conclusion only for high significance levels and for balanced sample sizes. Further, we have no reason to believe that the asymptotic behaviour of the logistic regression and asymptotic score test, including further covariates in addition to the genotype covariate, would be valid for low significance levels and unbalanced sample sizes. However, exact conditional logistic regression is available (Mehta and Patel, 1995) .
It is well known (Robinson and Jewell, 1991) that adjustment for non-confounding covariates always leads to a loss (or at best no gain) of precision in logistic regression models, however, not adjusting for confounding covariates will lead to a biased estimate for the genotype covariate. Pirinen et al. (2012) studied adding a non-confounding covariate, independent of the genotypes in the tested population, to the a logistic regression with genotype as covariate and using the Wald test. They found that in a simulation study that including non-confounding covariates typically increase power when the disease is common (prevalence above 0.2), but for rarer diseases, adding non-confounding covariates can often decrease the power to detect a genotypephenotype association. In a simulation study, Runde (2013) found that the power gain in including a nonconfounding covariate (when present) in a logistic regression score test is minimal compared to using the asymptotic CATT s unless the effect of the (standardized) environmental covariate corresponds to at least an odds ratio of 5 (sample sizes were n 1 = n 2 = 1000, prevalence was below 0.2 and significance level 0.05 was used).
Robust methods for disease-genotype association with covariates are available. So and Sham (2011) have developed a MAX3 type method combining three asymptotic logistic regression score tests. However, the validity of the method, in particular when using low significance levels, has to our knowledge not been investigated. Also, we have not seen exact conditional logistic regression used in combination with robust methods with covariates. This would be an interesting subject of future research.
Conclusions
We have studied seven test statistics that can be used to detect association between a dichotomous phenotype (diseased or not) and genotype. In GWA studies, for all monotone genetic models (including the recessive) to be detected with high power, the CATT 1/2 test statistic should not be used, but instead MAX3, CMAX or CLRT. If non-monotone effects are also of interest, the Pearson and MIN2 test statistics are found to perform well, also for over-and underdominant models .
We have shown how exact conditional enumeration, in absence of covariates, is a valid and powerful competitor to simulated permutations and asymptotic approximation for producing p-values. Drawing simulated permutations is an inefficient way of calculating a p-value for contingency tables of the sample sizes and significance levels used in genetic association studies. In our simulation study, calculation of exact conditional enumeration p-values was done in a fraction of a second, even for the largest sample size considered in this presentation (5000, 15, 000) . Exact conditional enumeration should be preferred to simulated permutations.
Further, it should be well known that p-values based on asymptotic approximations need not be valid, especially for small significance levels and unbalanced sample sizes, even when expected cell counts are at least 5. In an extensive simulation study, we have seen that for the asymptotic approximation for the test statistics studied here, test size may be as large as 20 times the nominal level. Lastly, the fact that exact conditional enumeration methods give low power compared to asymptotic methods for small sample sizes for 2 × 2 contingency tables due to discreteness (Lehmann, 1993) , is not transferrable to 2 × 3 contingency tables and the test statistics and sample sizes under study. In conclusion we find that exact conditional enumeration should be preferred to asymptotic approximation, both with respect to test size, power and computational considerations.
Software
A C++ program using the GNU Scientific Library that takes the entries of a 2 × 3 table as input and gives the value of all seven test statistics together with asymptotic, exact conditional enumeration and simulated permutations p-values is available upon request.
